Contemporary conditional cancer‐specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract-Reference-Cited by-同舟云学术

Contemporary conditional cancer‐specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract

Published:2020-02-27 Issue:7 Volume:121 Page:1154-1161
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Rosiello Giuseppe¹²^ORCID,Palumbo Carlotta¹³^ORCID,Knipper Sophie¹⁴^ORCID,Pecoraro Angela¹⁵,Luzzago Stefano¹⁶,Deuker Marina¹⁷,Mistretta Francesco A.⁶,Tian Zhe¹,Fossati Nicola²,Gallina Andrea²,Montorsi Francesco²,Shariat Shahrokh F.⁸⁹,Saad Fred¹,Briganti Alberto²,Karakiewicz Pierre I.¹

Affiliation:

1. Cancer Prognostics and Health Outcomes Unit, Division of UrologyUniversity of Montreal Health CenterMontreal Quebec Canada

2. Department of Urology and Division of Experimental Oncology, URI, Urological Research InstituteIRCCS San Raffaele Scientific InstituteMilan Italy

3. Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public HealthUniversity of BresciaBrescia Italy

4. Martini‐Klinik Prostate Cancer CenterUniversity Hospital Hamburg‐EppendorfHamburg Germany

5. Department of Urology,San Luigi Gonzaga HospitalUniversity of TurinTurin Italy

6. Department of UrologyEuropean Institute of OncologyMilan Italy

7. Department of UrologyUniversity Hospital FrankfurtFrankfurt am Main Germany

8. Department of Urology, Comprehensive Cancer CenterMedical University of ViennaVienna Austria

9. Institute of Urology and Reproductive HealthI.M. Sechenov First Moscow State Medical UniversityMoscow Russia

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.25877

Reference19 articles.

1. Cancer statistics, 2012

2. Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non–muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project

3. Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study

4. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

5. A novel risk‐based approach simulating oncological surveillance after radical nephroureterectomy in patients with upper tract urothelial carcinoma;Shigeta K;Eur Urol Oncol,2019

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncologic outcomes of patients treated with kidney-sparing surgery or radical nephroureterectomy for upper urinary tract urothelial cancer: a population-based study;Urologic Oncology: Seminars and Original Investigations;2024-01

2. Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease;Cancers;2023-12-20

3. Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods—what’s around the corner?;World Journal of Urology;2023-09-19

4. Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756);World Journal of Urology;2023-09-12

5. Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma;Translational Andrology and Urology;2023-09